Top Markets
#1 Black Phoenix Black Phoenix +17,837.96%
#2 Cash Dog in Hood Cash Dog in Hood +6,493.59%
#3 AgentFun.AI AgentFun.AI +54.83%
#4 up up +49.01%
#5 Arrow Arrow +48.53%
#6 Quai Network Quai Network +39.70%
#7 Octra Octra +37.04%
#8 Derive Derive +34.20%
#9 Block Street Block Street +31.33%
#10 B3 (Base) B3 (Base) +31.22%
Coin of the day
Black Phoenix Black Phoenix
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Theranexus Société Anonyme Theranexus Société Anonyme

Theranexus Société Anonyme

ALTHX
Kedudukan dalam Saham #15061
Theranexus société anonyme, a biopharmaceutical company, develops drug... Theranexus société anonyme, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders. The company's lead drug candidate is THN102, which is in Phase II clinical trial to treat sleep/wake disorders. It also develops THN201 for the treatment of neurocognitive disorders linked to Alzheimer's disease; and THN101 to treat neuropathic pain. The company was founded in 2013 and is based in Lyon, France.
Harga Saham
$4.66
Modal Pasaran
$43.92M
Perubahan (1 hari)
-0.63%
Perubahan (1 tahun)
338.04%
Negara
FR
Perdagangan Theranexus Société Anonyme (ALTHX)

Kategori

Healthcare
Hasil untuk Theranexus Société Anonyme (ALTHX)
Hasil pada Dec 2025 TTM: $958.56K
Menurut laporan kewangan terkini daripada Theranexus Société Anonyme, hasil semasa syarikat (TTM) ialah $958.56K. Pada tahun 2023, syarikat memperoleh hasil sebanyak $327.58K penurunan berbanding hasil pada tahun 2022 iaitu $445.05K. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Theranexus Société Anonyme dari 2015 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
2026 (TTM) $958.56K -59.66%
2024 $2.38M 625.31%
2023 $327.58K -26.39%
2022 $445.05K 64,912.44%
2021 $684.56 -99.81%
2020 $358.80K -43.29%
2019 $632.64K 396.28%
2018 $127.47K -28.14%
2017 $177.38K 86.15%
2016 $95.29K -84.37%
2015 $609.53K 0.00%
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 $52.05B 5,429,475.67%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.26B 1,278,390.46%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $14.92B 1,556,359.45%
US
UCB SA UCB SA
UCB SA
UCB.BR
 $9.08B 947,390.82%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.29B 656,137.28%
NL